Clinical data | |
---|---|
Other names | S/STR/STS[1] |
AHFS/Drugs.com | Monograph |
License data |
|
Routes of administration | Intramuscular, intravenous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 84% to 88% IM (est.)[2] 0% by mouth |
Elimination half-life | 5 to 6 hours |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
NIAID ChemDB | |
PDB ligand | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.323 |
Chemical and physical data | |
Formula | C21H39N7O12 |
Molar mass | 581.580 g·mol−1 |
3D model (JSmol) | |
Melting point | 12 °C (54 °F) [citation needed] |
| |
| |
(what is this?) (verify) |
Streptomycin is an antibiotic medication used to treat a number of bacterial infections,[3] including tuberculosis, Mycobacterium avium complex, endocarditis, brucellosis, Burkholderia infection, plague, tularemia, and rat bite fever.[3] For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide.[4] It is administered by injection into a vein or muscle.[3]
Common side effects include vertigo, vomiting, numbness of the face, fever, and rash.[3] Use during pregnancy may result in permanent deafness in the developing baby.[3] Use appears to be safe while breastfeeding.[4] It is not recommended in people with myasthenia gravis or other neuromuscular disorders.[4] Streptomycin is an aminoglycoside.[3] It works by blocking the ability of 30S ribosomal subunits to make proteins, which results in bacterial death.[3]
Albert Schatz first isolated streptomycin in 1943 from Streptomyces griseus.[5][6] It is on the World Health Organization's List of Essential Medicines.[7] The World Health Organization classifies it as critically important for human medicine.[8]
Zhu2001
was invoked but never defined (see the help page).